AlloSource Enrolls in ProChondrix CR Study

AlloSource enrolled the first patient in a prospective, multi-center study evaluating ProChondrix CR® fresh cryopreserved osteochondral allograft, for the repair of focal articular cartilage defects in the knee.

AlloSource developed ProChondrix CR cartilage restoration therapy to provide live, functional cells, an intact extracellular matrix...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us